Watch Ticker

Instil Bio, Inc. Common Stock

Go to Instil Bio, Inc. Common Stock Website

$24.74

2.51 (11.29%)

Live

Previous Close

$22.23

Day Range

$22.11 - $24.98

Previous Day Range

$22.22 - $24.4413

Market Cap

$145.8 million USD

Day Vol.

164874

Previous Day Vol.

336267

Currency

USD

Primary Exchange

Nasdaq

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a no...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Over 180 companies are developing 250+ bispecific antibodies targeting complex chronic diseases like cancer and autoimmune disorders, with innovative dual-targeting molecules offering superior therapeutic precision and efficacy.

Related tickers: TIL, ZLAB, BNTX, RHHBY.

Read Full Article

N/A - Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

Instil Bio, a clinical-stage biopharmaceutical company, announced the addition of John Maraganore, Ph.D., to the Board of Directors of its subsidiary Axion Bio, which is developing a PD-L1xVEGF bispecific antibody for solid tumors.

Related tickers: TIL.

Read Full Article

Trending Tickers

Please sign in to view